世卫组织宣布制定跨性别者和性别多元化人群健康指南

WHO announces the development of a guideline on the health of trans and gender diverse people

——《世界卫生组织-新闻》，2023年12月18日在线发布——

<WHO-News>, Published online: December 18, 2023

世卫组织-性别、权利和公平部门 - 多样性、公平和包容性 (GRE-DEI)、全球艾滋病毒、肝炎和性传播感染规划 (HHS) 以及性与生殖健康与研究 (SRH) 正在制定跨性别者和性别多元化人群的健康指南。

这项新指南将为卫生部门干预措施提供证据和实施指导，旨在增加跨性别者和性别多样化人士获得和利用优质且受尊重的卫生服务。该指南将重点关注5个领域：提供性别肯定护理，包括激素应用；卫生工作者的教育和培训，以提供性别包容的护理；为因需求而遭受人际暴力的跨性别者和性别多样化人士提供医疗保健；支持性别包容性护理的卫生政策以及对自决性别认同的法律承认。

根据世卫组织指南制定指南，指南制定小组 (GDG) 将由来自世卫组织所有区域的成员组成，以个人身份行事（不代表其所属的任何组织）。GDG的成员没有受委托，也没有获得任何经济补偿。本指南的GDG成员由世卫组织技术人员从具有相关技术专长的研究人员、最终用户（项目经理和卫生工作者）以及跨性别和性别多元化社区组织的代表中选出。

GDG将于2024年2月19日至21日在世卫组织日内瓦总部举行会议，目的是：

•检查建议评估、制定和评价（GRADE）证据概况的分级或用于为上述5个领域的建议提供信息的其他证据质量评估；

•解释证据，明确考虑利益和危害的总体平衡；

•制定建议，酌情考虑利益、危害、价值观和偏好、可行性、公平性、可接受性、资源需求和其他因素；和

•提出实施考虑因素并强调指南的研究差距。

根据世卫组织关于利益冲突的政策，公众和感兴趣的组织可以查阅本指南的GDG成员的简历，并向世卫组织通报他们对这些成员的看法。该名单包括21名成员。所有意见应在2024年1月8日之前通过电子邮件发送至hiv-aids@who.int。

WHO's Departments of Gender, Rights and Equity - Diversity, Equity and Inclusion (GRE-DEI), Global HIV, Hepatitis and Sexually Transmitted Infections Programmes (HHS), and Sexual and Reproductive Health and Research (SRH) are developing a guideline on the health of trans and gender diverse people.

This new guideline will provide evidence and implementation guidance on health sector interventions aimed at increasing access and utilization of quality and respectful health services by trans and gender diverse people. The guideline will focus in 5 areas: provision of gender-affirming care, including hormones; health workers education and training for the provision of gender-inclusive care; provision of health care for trans and gender diverse people who suffered interpersonal violence based in their needs; health policies that support gender-inclusive care, and legal recognition of self-determined gender identity. 

Following WHO guidance for guideline development a guideline development group (GDG) will be composed of members from all WHO regions acting in their individual capacity (not representing any organization with which they are affiliated). The members of the GDG are not commissioned and do not receive any financial compensation. Members of the GDG for this guideline were chosen by WHO technical staff among researchers with relevant technical expertise, among end-users (programme managers and health workers) and among representatives of trans and gender diverse community organisations.

The GDG will meet from 19 to 21 February 2024 at WHO’s headquarters in Geneva to:

•examine the grading of recommendations assessment, development and evaluation (GRADE) evidence profiles or other assessments of the quality of the evidence used to inform the recommendations on the 5 above mentioned areas;

•interpret the evidence, with explicit consideration of the overall balance of benefits and harms;

•formulate recommendations, taking into account benefits, harms, values and preferences, feasibility, equity, acceptability, resource requirements and other factors, as appropriate; and

•suggest implementation considerations and highlight research gaps for the guidelines.

In line with WHO policy on conflict of interest, members of the public and interested organizations can access the biographies of the GDG members for this guideline and inform WHO of their views about them. The list comprises 21 members. All comments should be sent by email to hiv-aids@who.int by 8 January 2024.

原文链接：https://www.who.int/news/item/18-12-2023-who-announces-the-development-of-a-guideline-on-the-health-of-trans-and-gender-diverse-people